Home ยป Amyotrophic Lateral Sclerosis
Health News
A global phase 3 trial of ravulizumab (Ultomiris) for adults with amyotrophic lateral sclerosis (ALS) is being discontinued following a data review, its manufacturer has announced. The CHAMPION-ALS
Read More
Health News
Researchers at Oregon State University have made an important advance toward understanding why certain cells in the nervous system are prone to breaking down and dying, which is
Read More
Health News
Researchers from the Institute of Neurosciences of the University of Barcelona (NeuroUB) and the Bellvitge Biomedical Research Institute (IDIBELL) and from the New York University (USA), studied the
Read More